Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter

被引：0
|
作者：
Stavrinides, Vasilis [1 ,2 ,3 ]
Giganti, Francesco [1 ,4 ]
Allen, Clare [4 ]
Kirkham, Alex [4 ]
Punwani, Shonit [4 ]
Freeman, Alex [5 ]
Norris, Joseph [1 ,2 ]
Pashayan, Nora [6 ]
Moore, Caroline M. [1 ,2 ]
Embertonk, Mark [1 ,2 ]
机构：
[1] UCL, Div Surg & Intervent Sci, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England
[3] Alan Turing Inst, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England
[5] Univ Coll London Hosp NHS Fdn Trust, Dept Pathol, London, England
[6] UCL, Inst Epidemiol & Hlth, Dept Appl Hlth Res, London, England
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 05期
基金：
英国医学研究理事会;
关键词：
MRI; PITFALLS; CANCER; PROMIS;
D O I：
10.1097/ju.0000000000001589
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1526 / 1528
页数：3
相关论文
共 50 条
  • [1] Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy
    Meng, Xiaosong
    Chao, Brian
    Chen, Fei
    Huang, Richard
    Taneja, Samir S.
    Deng, Fang-Ming
    JOURNAL OF UROLOGY, 2021, 205 (03) : 748 - 754
  • [2] Outcomes of Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions
    Gosein, Maria
    Pang, Emily
    Chang, Silvia
    Black, Peter
    Goldenberg, Larry
    Harris, Alison
    Yasenjiang, Jason
    Yousefi, Masoud
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2018, 69 (03): : 303 - 310
  • [3] Which men with non-malignant pathology at magnetic resonance imaging-targeted prostate biopsy and persistent PI-RADS 3-5 lesions should repeat biopsy?
    Castellani, Daniele
    Pace, Gianna
    Cecchini, Sara
    Franzese, Carmine
    Cicconofri, Andrea
    Romagnoli, Daniele
    Del Rosso, Alessandro
    Possanzini, Marco
    Paci, Enrico
    Dellabella, Marco
    Pierangeli, Tiziana
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (10) : 452.e9 - 452.e16
  • [4] PI-RADS 2.1 and structured reporting of magnetic resonance imaging of the prostate
    Hoetker, Andreas
    Donati, Olivio F.
    RADIOLOGE, 2021, 61 (09): : 802 - 809
  • [5] Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting
    Grey, Alistair D. R.
    Chana, Manik S.
    Popert, Rick
    Wolfe, Konrad
    Liyanage, Sidath H.
    Acher, Peter L.
    BJU INTERNATIONAL, 2015, 115 (05) : 728 - 735
  • [6] Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?
    Gomez-Gomez, Enrique
    Moreno Sorribas, Sara
    Valero-Rosa, Jose
    Blanca, Ana
    Mesa, Juan
    Salguero, Joseba
    Carrasco-Valiente, Julia
    Lopez-Ruiz, Daniel
    Jose Anglada-Curado, Francisco
    DIAGNOSTICS, 2021, 11 (08)
  • [7] Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
    Noh, Tae Il
    Shim, Ji Sung
    Kang, Seok Ho
    Cheon, Jun
    Kang, Sung Gu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging
    Lee, Jong Hoon
    Lee, Chung Un
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Jeon, Hwang Gyun
    PROSTATE INTERNATIONAL, 2024, 12 (03) : 134 - 138
  • [9] Early Second Round Targeted Biopsy of PI-RADS Score 3 or 4 in 256 Men With Persistent Suspicion of Prostate Cancer
    Pepe, Pietro
    Garufi, Antonio
    Priolo, Gian Domenico
    Pennisi, Michele
    Fraggetta, Filippo
    IN VIVO, 2019, 33 (03): : 897 - 901
  • [10] Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?
    Kim, Myong
    Ryu, Hoyoung
    Lee, Hak Jong
    Hwang, Sung Il
    Choe, Gheeyoung
    Hong, Sung Kyu
    WORLD JOURNAL OF UROLOGY, 2021, 39 (05) : 1463 - 1471
12345